Skip to main content
. Author manuscript; available in PMC: 2020 Aug 25.
Published in final edited form as: Eur J Endocrinol. 2019 Sep;181(3):301–309. doi: 10.1530/EJE-19-0176

Figure 3.

Figure 3

Plasma metanephrine results according to three levels of plasma normetanephrine in a general PPGL screening population (A), a supine endocrine testing population (B) and a cohort of confirmed PPGL (C). PMN, plasma metanephrine; PNM, plasma normetanephrine; PPGL, pheochromocytoma/paraganglioma, URL, upper reference limit of a (seated) reference range.